Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHG-Lock™ Device for Bacteremia Prevention in Cardiac Surgical Intensive Care Unit Patients: An Open Label Randomized Feasibility Pilot Study

NCT03309137 is registered in ClinicalTrials.gov with Alison Fox-Robichaud as lead sponsor.

NCT NCT03309137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03309137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHG-Lock™ Device for Bacteremia Prevention in Cardiac Surgical Intensive Care Unit Patients: An Open Label Randomized Feasibility Pilot Study
Lead sponsor
Alison Fox-Robichaud
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2017
Completion date
November 30, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, heart; surgery, heart, functional disturbance as result, infection